In an international first for Canadian cannabis, a shipment of cannabis tissue culture germplasm has successfully made its way from the prairies of Canada to a South African tissue culture laboratory and research facility.
The two companies involved, Mother Labs of Saskatchewan, Canada and Rascal Seed of South Africa have entered a long-term multi-year partnership whereby Mother will supply Rascal with premium, high-quality (22-30% THC and +3% terpenes) cannabis cultivars.
By trading verified pest and pathogen-free cannabis genetics in this way, Canadian companies can use experience and technology to support cannabis reforms that are currently sweeping the continent of Africa, where the regulated cannabis industry is predicted to be worth as much as $7.1 billion by 2023.
Mother Labs’ CEO Brian Bain told Benzinga, “This successful delivery and long-term partnership signals a new age of cannabis distribution on a global level. Mother Labs is leveraging our extensive list of high-performing cultivars and industry partnerships to help bring South Africa’s medical community up to speed with emerging genetic trends and unique cannabinoid/terpene profiles. Mother looks forward to continuing to build on the relationship with Rascal Seed in South Africa.”
Encuentra nuestro contenido en Español en El Planteo:
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!
